ImmuPharma PLC Ownership
| IMM Stock | 1.22 0.13 11.93% |
Shares in Circulation | First Issued 2006-06-30 | Previous Quarter 416.4 M | Current Value 416.4 M | Avarage Shares Outstanding 177.6 M | Quarterly Volatility 103.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
ImmuPharma |
ImmuPharma Stock Ownership Analysis
About 48.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.69. Some equities with similar Price to Book (P/B) outperform the market in the long run. ImmuPharma PLC recorded a loss per share of 0.01. The entity last dividend was issued on the 14th of December 2021. The firm had 1:1 split on the 17th of August 2022. To learn more about ImmuPharma PLC call XIV FCCA at 44 20 7206 2650 or check out https://www.immupharma.co.uk.ImmuPharma PLC Outstanding Bonds
ImmuPharma PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ImmuPharma PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ImmuPharma bonds can be classified according to their maturity, which is the date when ImmuPharma PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in ImmuPharma Stock
ImmuPharma PLC financial ratios help investors to determine whether ImmuPharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImmuPharma with respect to the benefits of owning ImmuPharma PLC security.